bluebird bio Inc (NAS:BLUE)
$ 0.6078 0.0338 (5.89%) Market Cap: 117.15 Mil Enterprise Value: 240.30 Mil PE Ratio: 0 PB Ratio: 0.29 GF Score: 25/100

bluebird bio Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 25, 2021 / 05:00PM GMT
Release Date Price: $18.2 (+8.49%)
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Good day, and welcome to our meeting session, of our company presentation with fireside chats, this year's Global Healthcare conference. I am Mani Foroohar, Senior Analyst in Genetic Medicines team. And I'm very fortunate to host Nick Leschly, Chip Baird and Philip Gregory from bluebird bio. How is everybody doing this morning or midday, I suppose?

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Great.

William D. Baird
bluebird bio, Inc. - CFO & Interim Principal Accounting Officer

Good.

Mani Foroohar;Nick Leschly
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst;bluebird bio, Inc. - President,

Nick, do you want to start off with -- I know you guys have some comments you want to make on sort of recent events. Do you want to start off there before we dive into questions?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot